United States - Patent - US FTC Continues Aggressive Scrutiny Of Pharmaceutical Patents Listed In The Orange Book mondaq.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mondaq.com Daily Mail and Mail on Sunday newspapers.
The Federal Trade Commission ("FTC") has filed an amicus brief in Teva Branded Pharmaceuticals Products R&D, Inc. v. Amneal Pharmaceuticals of New York, LLC to further the agency's.
On November 7, 2023, the Federal Trade Commission ("FTC") announced it is challenging over 100 patents as improperly listed in the Food and Drug Administration's ("FDA") publication.